Navigation Links
Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Date:1/29/2008

Weighted average

number of shares

outstanding: 13,235,755 13,235,755

Table 5

Amicus Therapeutics, Inc.

Reconciliation of GAAP to non-GAAP Measures for the

Statement of Operations Information for Year Ended December 31, 2006

(Unaudited)

(In thousands, except share and per share amounts)

Change

in Fair

Value of Preferred

Non- Warrant Stock Deemed Stock GAAP as

GAAP Liability Accretion Dividend Compensation Reported

Income Statement

Classifications:

Research and

development $(31,924) $- $- $- $(1,706) $(33,630)

General and

administrative (10,733) (1,544) (12,277)

Depreciation and

amortization (952) (952)

Interest income 1,990 1,990

Interest expense (273) (273)

Change in fair

value of warrant

liability - (23) (23)

Other expense (1,180) (1,180)

Preferred stock

accretion - (159) (159)

Deemed dividend - (19,424) (19,424)

Summary:

Net loss: $(43,072) $(23) $(159) $(19,424) $(3,250) $(65,928)

Net loss per

share - basic

and diluted: $(58.52) $(0.03) $(0.22) $(26.39) $(4.42) $(89.58)

Weighted average

number of shares

outstanding: 735,967 735,967 '/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
2. Amicus Therapeutics to Host R&D Day
3. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
4. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
5. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
7. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
11. Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Boulder, CO / Rootstown, OH (PRWEB) January 22, 2015 ... sensitive detection platform, announced today that it has received AOAC-PTM ... O26, O45, O1O3, O111, O121, and O145; collectively referred to ... (E. coli) O157, at 1 colony forming unit (cfu) per ...
(Date:1/22/2015)... Switzerland (PRWEB) January 22, 2015 Selexis ... characterized mammalian Research Cell Banks (RCBs) used for drug ... Research Cell Banks will include Next-Generation Sequencing ... genetic architecture de-risks biologic manufacturing by ensuring the integrity ...
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... (Nasdaq and SWX: BMRN) announced today that AnGes ... Japan, has,received approval for its Marketing Application for ... and Welfare,(MHLW) for the treatment of patients with ... to work with AnGes in bringing the first ...
... Used for Marketing in 2008 --, HARBIN, ... Inc. (the "Company") (OTC Bulletin Board: CKGT), a,vertically ... of cactus-based consumer products in China, today announced ... agreement with T Squared,Investments LLC (the "Investor"), whereby ...
... With employee performance module implemented in just few months, ... ... personal growth, ... of web-based employee performance and talent management software,today announced that ...
Cached Biology Technology:Naglazyme Approved by Japanese Ministry of Health 2Naglazyme Approved by Japanese Ministry of Health 3Naglazyme Approved by Japanese Ministry of Health 4China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing 2Beaumont Hospitals in Michigan Selects Halogen Software for Pay for Performance System 2
(Date:12/10/2014)... 2014 You,ve been here before: you desperately need to sign ... key or the answer to your secret question. What,s your dog,s ... Hoyos Labs , a digital infrastructure security company, launches ... frustration that comes with usernames, passwords and PINs – 1U ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist Medical ... for its School of Medicine. Funding for this $50 million ... will be publicly launched next summer. The ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ...
(Date:12/10/2014)... Dec. 08, 2014 Research and Markets ( ... "Biometrics Market in Japan 2014-2018" report to their ... The integration of biometrics and smart cards for ... driver,s license is one of the major trends witnessed ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... EUGENE, Ore. -- (Aug. 22, 2011) -- Seeing and exploring ... when taking in a new experience, say University of Oregon ... In experiments in the UO lab of Clifford G. Kentros, ... how neurons fire in the hippocampus of rats as they ...
... JUPITER, FL, August 22, 2011 Working closely with ... Florida campus of The Scripps Research Institute have helped identify ... damage to the genome, the entirety of an organism,s hereditary ... Nature on August 21, 2011, could not only explain ...
... The U.S. Department of Health and Human Services, Health ... post-doctoral training programs in dental public health at Case ... in oral health. Case Western Reserve University ... nearly $2.6 million. The funding will support efforts to ...
Cached Biology News:Experience puts the personal stamp on a place in memory 2Experience puts the personal stamp on a place in memory 3Scripps Research scientists help pinpoint cause of stress-related DNA damage 2CWRU School of Dental Medicine receives $2.6 million in grants 2
Canine Aortic Smooth Muscle Cells (CnAOSMC) (>500,000 cells)...
... cell lines in combination with the corresponding ... Kits are only functional in combination with ... be transfected with this kit. The corresponding ... in percent (Efficiency [%] / viability [%]). ...
... Human Pathogenic Viruses The ... (NCPV) preserves well characterised, authenticated ... secure facility, and NCPV is ... or nucleic acids derived from ...
B-FABP (FL-132)...
Biology Products: